Anteris pumped as heart valve shines
ASX biotech Anteris Technologies has revealed flawless results from trials of its artificial heart valve. Read that and more in our health wrap. Anteris has just presented the latest data from the DurAVR First-In-Human Study at the TVT Conference. Results show that DurAVR THV continues to maintain excellent haemodynamic performance at one year and 30-day … [Read more…]